Navigation Links
ERT Reports Second Quarter 2011 Operating Results
Date:8/1/2011

onsolidated Statements of Operations(in thousands, except per share amounts)(unaudited)Three Months Ended June 30,Six Months Ended June 30,2010201120102011Net revenues:Services $
8,697 $
22,416 $
33,532 $
46,393 Site support10,399 20,433 17,432 38,155 Total net revenues29,096 42,849 50,964 84,548 Costs of revenues:Cost of services8,325 13,615 15,636 26,771 Cost of site support4,957 13,189 7,756 23,312 Total costs of revenues13,282 26,804 23,392 50,083 Gross margin15,814 16,045 27,572 34,465 Operating expenses:Selling and marketing3,941 4,426 7,349 8,601 General and administrative9,753 7,247 14,498 14,755 Research and development1,069 1,802 1,927 3,185 Total operating expenses14,763 13,475 23,774 26,541 Operating income1,051 2,570 3,798 7,924 Foreign exchange gains (losses)399 (266)479 (1,275)Other (expense) income, net(3)(168)17 (269)Income before income taxes1,447 2,136 4,294 6,380 Income tax provision621 355 1,716 1,506 Net income $
826 $
,781 $
2,578 $
4,874 Net income per share:Basic $
.02 $
.04 $
.05 $
.10 Diluted $
.02 $
.04 $
.05 $
.10 Shares used in computing net income per share:Basic48,831 49,146 48,753 49,021 Diluted49,383 49,330 49,114 49,291 eResearchTechnology, Inc. and SubsidiariesConsolidated Balance Sheets(in thousands, except share and per share amounts)(unaudited)December 31, 2010June 30, 2011ASSETSCurrent assets:Cash and cash equivalents $
30,343 $
31,601 Short-term investments50 50 Investment in marketable securities48 972 Accounts receivable less allowance for doubtful accountsof $515 and $555, respectively37,236 34,525 Inventory4,698 ,893 Prepaid income taxes,988 3,216 Prepaid expenses and other4,393 5,886 Deferred income taxes3,431 3,431 Total current assets82,787 90,574 Property and equipment, net42,615 47,767 Goodwill71,637 77,357 Intangible assets7,187 5,702 Other assets9 80 Total assets $
214,835 $
232,080 LIABILITIES AND STOCKHOLDERS' EQUITYCurrent liabilities:Acco
'/>"/>
SOURCE ERT
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. Spherix Reports Second Quarter Earnings
3. Tapestry Reports Second Quarter 2007 Results
4. Callisto Reports on Second-Quarter 2007 Milestones
5. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
6. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
7. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
8. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
9. Biopure Reports on Meeting with the FDA
10. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
11. NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... – Small Cap IR issues report. Recently, Arrayit Corporation ... blood card technology to Vivos, Global Genome Vault, the ... an impervious, impenetrable and permanent DNA storage vault, able ... Earth, a safe and secure nuclear blast-proof, underground shelter ... rapid collection, separation, drying and storage of human genomic ...
(Date:6/30/2015)... N.C. , June 30, 2015  Marken, the ... to the life sciences industry, has been granted permission ... patient shipment of clinical drug product in Korea.  This ... South Korea to continue receiving their clinical ... System (MERS). The emergency was caused by ...
(Date:6/30/2015)...  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) announces ... of StockholdersWhen:Tuesday, June 30 at 5:10 p.m. ET / ... log onto our website listed above.   ... event, a replay of the webcast will be available ... ABOUT ISIS PHARMACEUTICALS, INC. Isis is ...
Breaking Medicine Technology:Small Cap IR - Empowering the Age of Genetic Enlightenment 2Marken Delivers Direct To Patients During MERS Outbreak 2Marken Delivers Direct To Patients During MERS Outbreak 3Webcast Alert: Corporate Presentation at the 2015 Isis Pharmaceuticals Annual Stockholder Meeting 2Webcast Alert: Corporate Presentation at the 2015 Isis Pharmaceuticals Annual Stockholder Meeting 3
... Feb. 23 MAP,Pharmaceuticals, Inc. (Nasdaq: ... 3 clinical trial of Unit Dose Budesonide (UDB) ... The Company announced that the clinical,trial did not ... by,changes from baseline in nighttime and daytime composite ...
... BCRX ) today announced that the full ... peramivir in patients hospitalized for influenza was presented by ... Professor, Divisions of Infectious Diseases and Organ Transplantation at ... the XI International Symposium on Respiratory Viral Infections taking ...
Cached Medicine Technology:MAP Pharmaceuticals Announces Phase 3 Study of Unit Dose Budesonide in Children With Asthma Did Not Meet Primary Endpoints 2MAP Pharmaceuticals Announces Phase 3 Study of Unit Dose Budesonide in Children With Asthma Did Not Meet Primary Endpoints 3Data from Phase 2 Study of Peramivir in Patients Hospitalized with Influenza Presented at the XI International Symposium on Respiratory Viral Infections 2Data from Phase 2 Study of Peramivir in Patients Hospitalized with Influenza Presented at the XI International Symposium on Respiratory Viral Infections 3Data from Phase 2 Study of Peramivir in Patients Hospitalized with Influenza Presented at the XI International Symposium on Respiratory Viral Infections 4Data from Phase 2 Study of Peramivir in Patients Hospitalized with Influenza Presented at the XI International Symposium on Respiratory Viral Infections 5
(Date:6/30/2015)... ... 30, 2015 , ... University Post-Acute Rehab recently released a ... rehab center’s patients and their experiences at the facility. Medicare granted University Post-Acute ... Each patient attests to the high rating, which is predominantly based on cleanliness, ...
(Date:6/30/2015)... ... 2015 , ... According to a June 15th report from USC ... sensory stimuli can be used to “decrease children’s anxiety and negative responses during oral ... will compare patient experience in a “typical dental environment” with one that provides “visual, ...
(Date:6/30/2015)... ... 30, 2015 , ... Broadway by the Sea posted its newest YouTube video ... testimonials. Medicare rated the care center as a five-star location based on a comprehensive ... future patients a firsthand look at the facility’s satisfied residents. , “In this ...
(Date:6/30/2015)... ... June 30, 2015 , ... After many requests from ... its here, http://www.express-glasses.com is proud to announce its collaboration with DHL ... shipping with DHL Express when calling or visiting the express glasses website. express ...
(Date:6/30/2015)... ... June 30, 2015 , ... The ... a federal multidistrict litigation now underway in the U.S. District Court, Eastern District ... Conference. According to the Court’s calendar, that conference has now been scheduled for ...
Breaking Medicine News(10 mins):Health News:Patients of University Post-Acute Rehab Support Five-Star Rating in New Video 2Health News:New Study Aims to Determine if Sensory Stimuli can Ease Dental Anxiety in Children, Notes Medical Center Dental Care 2Health News:New Study Aims to Determine if Sensory Stimuli can Ease Dental Anxiety in Children, Notes Medical Center Dental Care 3Health News:Broadway by the Sea Video Promotes Top Quality Service 2Health News:Eyeglasses Online - Express Glasses Announcing New International Shipping Using DHL 2Health News:Progress of Federal Xarelto Lawsuits Pending in Multidistrict Litigation to Be Discussed During July 9th Status Conference 2Health News:Progress of Federal Xarelto Lawsuits Pending in Multidistrict Litigation to Be Discussed During July 9th Status Conference 3
... November 2, 2008 at this year,s liver ... 4, SAN FRANCISCO, Oct. 28 The goal of ... Paul Angulo, was to determine the,effects of fatty liver disease ... is especially important as nonalcoholic fatty liver disease,(NAFLD) is the ...
... 28 CoLucid Pharmaceuticals, Inc., an,innovative biotechnology ... disorders, announced today that it has appointed ... In this position, Hogan will apply more,than ... and biopharmaceutical,industries to drive CoLucid,s business development ...
... WOBURN, Mass., Oct. 28 Galenea Corp.,today announced ... and its,academic collaborators that gives Galenea a license ... other related disorders. The license grants,Galenea the exclusive ... indole-based agonists., The licensed compounds have demonstrated ...
... Brain Injury Association (CALBIA), a non-profit membership ... those affected by brain injury, together with the ... representing individuals sustaining traumatic brain injury , ... nation’s most important professional medical/legal conferences dealing with ...
... hemoglobin A1c monitoring market is forecast to surpass $272 million by ... population. Other growth drivers include greater glucose control and product innovations ... ... Jose, CA (PRWEB) October 28, 2008 -- World Health Organization forecasts ...
... you,re an individual watching the stock market crash or ... in the journal Psychological Science, examines how ... their behavior more than young adults when under stress ... looked at how stress affects decision making, even though ...
Cached Medicine News:Health News:Severe Health Risks Follow Adults Who Were Diagnosed With Nonalcoholic Fatty Liver Disease as Children 2Health News:CoLucid Pharmaceuticals Names Linda Hogan VP of Business Development 2Health News:CoLucid Pharmaceuticals Names Linda Hogan VP of Business Development 3Health News:Galenea and Organix Announce Exclusive License Agreement for 5-HT2C Agonists for the Treatment of Obesity 2Health News:Galenea and Organix Announce Exclusive License Agreement for 5-HT2C Agonists for the Treatment of Obesity 3Health News:California Brain Injury Association and Scarlett Law Group Conduct Medical/Legal Conference on Traumatic Brain Injury November 21 - 23rd, 2008 2Health News:California Brain Injury Association and Scarlett Law Group Conduct Medical/Legal Conference on Traumatic Brain Injury November 21 - 23rd, 2008 3Health News:Global Hemoglobin A1c Monitoring Market to Touch $272 Million by 2012, According to New Report by Global Industry Analysts, Inc. 2Health News:Global Hemoglobin A1c Monitoring Market to Touch $272 Million by 2012, According to New Report by Global Industry Analysts, Inc. 3Health News:Stress affects older adults more than young adults 2
The adult blanket provides full coverage for patients of all sizes. The generous size and versatility of these blankets include extra material for the shoulders and feet. The foot drape also reduces ...
This revolutionary system combines the CSZ Head Wrap and Patient Vest for a non-invasive whole body hypothermia system. This method of cooling the patient allows for early treatment that is fast, cos...
The fabric is antistatic and non-linting and is both oil and water repellent.These superior blankets are an environmental friendly alternative to disposable blankets....
The Bair Hugger outpatient blanket makes it easy to give your patients the benefit of prewarming and enhance patient comfort during outpatient procedures....
Medicine Products: